Alumis Corporate Presentation - June 2026 2.1 MB Envudeucitinib ONWARD1 and ONWARD2 Phase 3 Data Presentation 2.7 MB Alumis Envudeucitinib ONWARD Phase 3 Plaque Psoriasis Trial Results Event Presentation 901.2 KB
